Video: Angus Russell of Shire on the social responsibility of companies working with rare diseases – at World Orphan Drug Congress USA 2012

Angus Russell, Chief Executive Officer of Shire, presented at World Orphan Drug Congress USA earlier this year on the topic, ‘The social responsibility of companies working with orphan diseases.’

Watch the video below to hear what he has to say about:

• The history of Shire and its entrance into the rare disease space
• The future role of regenerative medicine in rare disease treatments
• Knowing the patient vs. market share – value creation or self-fulfillment?
• Shire’s 4 P’s: payers, policy makers, physicians and patients

Check out the video below for insights on the above and more! 

The World Orphan Drug Congress USA is the largest and most global commercially-focused orphan drug event. Download the prospectus for more information.